Enzyme immunoassay (EIA)/enzyme-linked immunosorbent assay (ELISA) - PubMed (original) (raw)
. 2005 Dec;51(12):2415-8.
doi: 10.1373/clinchem.2005.051532. Epub 2005 Sep 22.
Affiliations
- PMID: 16179424
- DOI: 10.1373/clinchem.2005.051532
Enzyme immunoassay (EIA)/enzyme-linked immunosorbent assay (ELISA)
Rudolf M Lequin. Clin Chem. 2005 Dec.
Abstract
This brief note addresses the historical background of the invention of the enzyme immunoassay (EIA) and enzyme-linked immunosorbent assay (ELISA). These assays were developed independently and simultaneously by the research group of Peter Perlmann and Eva Engvall at Stockholm University in Sweden and by the research group of Anton Schuurs and Bauke van Weemen in The Netherlands. Today, fully automated instruments in medical laboratories around the world use the immunoassay principle with an enzyme as the reporter label for routine measurements of innumerable analytes in patient samples. The impact of EIA/ELISA is reflected in the overwhelmingly large number of times it has appeared as a keyword in the literature since the 1970s. Clinicians and their patients, medical laboratories, in vitro diagnostics manufacturers, and worldwide healthcare systems owe much to these four inventors.
Comment in
- Perspective on the historical note on EIA/ELISA by Dr. R.M. Lequin.
Engvall E. Engvall E. Clin Chem. 2005 Dec;51(12):2225. doi: 10.1373/clinchem.2005.059618. Clin Chem. 2005. PMID: 16306091 No abstract available. - The rise of EIA/ELISA.
van Weemen BK. van Weemen BK. Clin Chem. 2005 Dec;51(12):2226. doi: 10.1373/clinchem.2005.059626. Clin Chem. 2005. PMID: 16306092 No abstract available. - Historical background of the invention of EIA and ELISA.
Avrameas S. Avrameas S. Clin Chem. 2006 Jul;52(7):1430-1; author reply 1431. doi: 10.1373/clinchem.2006.069724. Clin Chem. 2006. PMID: 16798968 No abstract available.
Similar articles
- A short history, principles, and types of ELISA, and our laboratory experience with peptide/protein analyses using ELISA.
Aydin S. Aydin S. Peptides. 2015 Oct;72:4-15. doi: 10.1016/j.peptides.2015.04.012. Epub 2015 Apr 20. Peptides. 2015. PMID: 25908411 - Historical background of the invention of EIA and ELISA.
Avrameas S. Avrameas S. Clin Chem. 2006 Jul;52(7):1430-1; author reply 1431. doi: 10.1373/clinchem.2006.069724. Clin Chem. 2006. PMID: 16798968 No abstract available. - Perspective on the historical note on EIA/ELISA by Dr. R.M. Lequin.
Engvall E. Engvall E. Clin Chem. 2005 Dec;51(12):2225. doi: 10.1373/clinchem.2005.059618. Clin Chem. 2005. PMID: 16306091 No abstract available. - Chapter 5. Potential contribution of sero-epidemiological analysis for monitoring malaria control and elimination: historical and current perspectives.
Drakeley C, Cook J. Drakeley C, et al. Adv Parasitol. 2009;69:299-352. doi: 10.1016/S0065-308X(09)69005-9. Adv Parasitol. 2009. PMID: 19622411 Review. - European Union funded project on the development of a whole complement deficiency screening ELISA-A story of success and an exceptional manager: Mohamed R. Daha.
Würzner R, Tedesco F, Garred P, Mollnes TE, Truedsson L, Turner MW, Sommarin Y, Wieslander J, Sim RB. Würzner R, et al. Mol Immunol. 2015 Nov;68(1):63-6. doi: 10.1016/j.molimm.2015.05.003. Epub 2015 May 23. Mol Immunol. 2015. PMID: 26006049 Review.
Cited by
- Small molecule inhibitors against PD-1/PD-L1 immune checkpoints and current methodologies for their development: a review.
Liu C, Seeram NP, Ma H. Liu C, et al. Cancer Cell Int. 2021 Apr 27;21(1):239. doi: 10.1186/s12935-021-01946-4. Cancer Cell Int. 2021. PMID: 33906641 Free PMC article. Review. - The relationship between sphingomyelin and ceramide levels and soft neurological signs in ADHD.
Güleç A, Türkoğlu S, Kocabaş R. Güleç A, et al. J Neural Transm (Vienna). 2025 Jan;132(1):157-168. doi: 10.1007/s00702-024-02831-w. Epub 2024 Sep 9. J Neural Transm (Vienna). 2025. PMID: 39249516 - Assessment of the Salivary Concentrations of Selected Immunological Components in Adult Patients in the Late Period after Allogeneic Hematopoietic Stem Cell Transplantation-A Translational Study.
Brodzikowska A, Kochańska B, Bogusławska-Kapała A, Strużycka I, Górski B, Miskiewicz A. Brodzikowska A, et al. Int J Mol Sci. 2024 Jan 25;25(3):1457. doi: 10.3390/ijms25031457. Int J Mol Sci. 2024. PMID: 38338734 Free PMC article. - 3D Printing for Cancer Diagnosis: What Unique Advantages Are Gained?
Zhang Y. Zhang Y. ACS Mater Au. 2023 Aug 28;3(6):620-635. doi: 10.1021/acsmaterialsau.3c00046. eCollection 2023 Nov 8. ACS Mater Au. 2023. PMID: 38089653 Free PMC article. Review. - Analysis of the Mechanism of GuizhiFuling Wan in Treating Adenomyosis Based on Network Pharmacology Combined with Molecular Docking and Experimental Verification.
Shi Y, Zhang C, Wang X, Wang Z, Zhang Y, Liu Z, Wang X, Shi W. Shi Y, et al. Evid Based Complement Alternat Med. 2022 Aug 26;2022:6350257. doi: 10.1155/2022/6350257. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 36065269 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources